Long intergenic non-protein coding RNA 2391 (LINC02391)

Long intergenic non-protein coding RNA 2391 (LINC02391) is a member of the long intergenic non-coding RNA (lincRNA) class, characterized by transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[1][7]. LINC02391 is catalogued in gene databases but lacks detailed functional or disease-specific characterization[1]. LincRNAs are increasingly recognized as important gene regulatory elements acting at transcriptional, post-transcriptional, and epigenetic levels. They are involved in processes such as chromatin remodeling, transcription regulation, and modulation of microRNA activity, potentially acting as molecular sponges[5][7]. Although many lincRNAs are linked to processes like cell proliferation, apoptosis, and oncogenesis, there is currently no published evidence specifically implicating LINC02391 in any disease, drug interaction, or clinical biomarker utility[1][5][7]. Note: The entry is not considered a classical therapeutic target such as a receptor, enzyme, or transporter. Its main molecular classification is as a non-coding RNA. No aliases or alternate names beyond LINC02391 are recorded, and no specific interacting drugs, mechanisms of action, or safety concerns have been described in the available literature.

Other names

LINC02391